摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-氧代-3,4-二氢-2H-苯并[b][1,4]噻嗪-6-甲醛 | 262426-58-4

中文名称
3-氧代-3,4-二氢-2H-苯并[b][1,4]噻嗪-6-甲醛
中文别名
——
英文名称
3-oxo-3,4-dihydro-2H-1,4-benzothiazine-6-carboxaldehyde
英文别名
3-oxo-3,4-dihydro-2H-benzo[1,4]thiazine-6-carbaldehyde;3-oxo-3,4-dihydro-2H-1,4-benzothiazine-6-carbaldehyde;3-oxo-3,4-dihydro-2H-benzo[1,4]thiazine-6-carboxaldehyde;3-oxo-3,4-dihydro-2H-benzo[1,4]thiazine-6-carboxylic acid;3-Oxo-3,4-dihydro-2H-benzo[b][1,4]thiazine-6-carbaldehyde;3-oxo-4H-1,4-benzothiazine-6-carbaldehyde
3-氧代-3,4-二氢-2H-苯并[b][1,4]噻嗪-6-甲醛化学式
CAS
262426-58-4
化学式
C9H7NO2S
mdl
——
分子量
193.226
InChiKey
GBOGHJYGGDERQX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    428.5±45.0 °C(Predicted)
  • 密度:
    1.380±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.9
  • 重原子数:
    13
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.11
  • 拓扑面积:
    71.5
  • 氢给体数:
    1
  • 氢受体数:
    3

安全信息

  • 海关编码:
    2934999090

SDS

SDS:cd380b76a65d870e53bdc28ef0eb772e
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-(6-methoxy-[1,5]naphthyridin-4-yl)-4,5,6,7-tetrahydro-2H-indazol-5-ylamine3-氧代-3,4-二氢-2H-苯并[b][1,4]噻嗪-6-甲醛 在 sodium cyanoborohydride 作用下, 以 乙腈 为溶剂, 生成 6-{[2-(6-methoxy-[1,5]naphthyridin-4-yl)-4,5,6,7-tetrahydro-2H-indazol-5-ylamino]-methyl}-4H-benzo[1,4]thiazin-3-one
    参考文献:
    名称:
    Tetrahydroindazole inhibitors of bacterial type II topoisomerases. Part 2: SAR development and potency against multidrug-resistant strains
    摘要:
    We have previously reported a novel class of tetrahydroindazoles that display potency against a variety of Gram-positive and Gram-negative bacteria, potentially via interaction with type II bacterial topoisomerases. Herein are reported SAR investigations of this new series. Several compounds possessing broad-spectrum potency were prepared. Further, these compounds exhibit activity against multidrug-resistant Gram-positive microorganisms equivalent to that against susceptible strains. (c) 2007 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2007.03.004
  • 作为产物:
    描述:
    acetic acid 3-oxo-3,4-dihydro-2H-benzo[1,4]thiazin-6-ylmethyl ester 在 lithium hydroxide monohydrate 、 戴斯-马丁氧化剂 作用下, 以 甲醇二氯甲烷 为溶剂, 反应 3.0h, 生成 3-氧代-3,4-二氢-2H-苯并[b][1,4]噻嗪-6-甲醛
    参考文献:
    名称:
    [EN] INHIBITORS OF DNA GYRASE FOR THE TREATMENT OF BACTERIAL INFECTIONS
    [FR] INHIBITEURS D'ADN GYRASE DE TRAITEMENT D'INFECTIONS BACTÉRIENNES
    摘要:
    公开号:
    WO2014057415A4
点击查看最新优质反应信息

文献信息

  • Methods for treating neisseria gonorrhoeae infection with substituted 1,2-dihydro-2A,5,8A-triazaacenaphthylene-3,8-diones
    申请人:GlaxoSmithKline Intellectual Property Development Limited
    公开号:US10702521B2
    公开(公告)日:2020-07-07
    The present invention relates to methods for treating Neisseria Gonorrhoeae infection which comprises administering to a subject in need thereof novel 1,2-dihydro-2a,5,8a-triazaacenaphthylene-3,8-dione compounds: or pharmaceutically acceptable salts thereof and/or corresponding pharmaceutical compositions.
    本发明涉及治疗淋病双球菌感染的方法,包括向需要的受试者施用新型1,2-二氢-2a,5,8a-三氮杂蒽-3,8-二酮化合物:或其药学上可接受的盐和/或相应的药物组合物。
  • [EN] COMPOUNDS<br/>[FR] COMPOSÉS
    申请人:GLAXO GROUP LTD
    公开号:WO2004002992A1
    公开(公告)日:2004-01-08
    Cyclohexane and cyclohexene derivatives and pharmaceutically acceptable derivatives thereof useful in methods of treatment of bacterial infections in mammals, particularly man. A compound of formula (I) or a pharmaceutically acceptable derivative thereof: (I) RA is an optionally substituted bicyclic carbocyclic or heterocyclic ring system of structure: containing 0-3 heteroatmoms in each ring in which: at least one of the rings (x) and (y) is aromatic; one of Z4 and Z5 is C or N and the other is C; Z3 is N, NR13, O, S(O)x, CO, CR1 or CR1R1a; Z1 and Z2 are indendently a 2 or 3 atom linker group each atom of which is independently selected from N, NR13, O, S(O)x, CO, CR1, and CR1R1a; such that each ring is independently substituted with 0-3 groups R1 and/or R1a. R4 is a group -CH2-R51in which R51 is selected from: (C4-8) alkyl; hydroxy (C4-8) alkyl; (C1-4)alkoxy (C4-8)alkyl; (C1-4) alkanoyloxy (C4-8) alkyl; (C3-8)cycloalkyl (C 4-8)alkyl;hydroxy-, (C1-6) alkoxy- or (C1-6) alkanoyloxy-(C3-8)cycloalkyl (C4-8)alkyl; cyano(C4-8)alkyl; (C4-8)alkenyl; (C4-8)alkynyl; tetrahydrofuryl; mono- or di-(C1-6)alkylamino (C4-8)alkyl; acylamino (C4-8)alkyl; C(1-6)alkyl- or acyl-aminocarbonyl (C4-8) alkyl; mono- or di- (C1-6)alkylamino(hydroxy) (C4-8)alkyl; or R4 is a group-U-R52 where R52 is an optionally substituted bicyclic carbocyclic or heterocyclic ring system (A): containing up to four heteroatoms in each ring in which at least one of rings (a) and (b) is aromatic; X1 is C or N when part of an aromatic ring or CR14 when part of a non-aromatic ring.
    环己烷和环己烯衍生物及其在治疗哺乳动物,特别是人类细菌感染方法中有用的药用可接受衍生物。一种公式(I)的化合物或其药用可接受的衍生物:(I) RA是一个可选地取代的双环碳环或杂环环系结构:包含每个环中的0-3个杂原子,其中:至少一个环(x)和(y)是芳香的;Z4和Z5中的一个为C或N,另一个为C;Z3是N,NR13,O,S(O)x,CO,CR1或CR1R1a;Z1和Z2是独立选择的2或3原子连接基团,每个原子独立地选自N,NR13,O,S(O)x,CO,CR1,和CR1R1a;使得每个环独立地用0-3个组R1和/或R1a取代。R4是一个组-CH2-R51,其中R51选自:(C4-8)烷基;羟基(C4-8)烷基;(C1-4)烷氧基(C4-8)烷基;(C1-4)烷酰氧基(C4-8)烷基;(C3-8)环烷基(C4-8)烷基;羟基-,(C1-6)烷氧基-或(C1-6)烷酰氧基-(C3-8)环烷基(C4-8)烷基;氰基(C4-8)烷基;(C4-8)烯基;(C4-8)炔基;四氢呋喃基;单或二-(C1-6)烷基氨基(C4-8)烷基;酰氨基(C4-8)烷基;C(1-6)烷基-或酰基-氨基甲酰基(C4-8)烷基;单或二-(C1-6)烷基氨基(羟基)(C4-8)烷基;或R4是一个组-U-R52,其中R52是一个可选地取代的双环碳环或杂环环系(A):每个环中含最多四个杂原子,其中至少一个环(a)和(b)是芳香的;X1是C或N当其作为芳香环的一部分,或CR14当其作为非芳香环的一部分。
  • Bicyclic pyrazole compounds as antibacterial agents
    申请人:Allison D. Brett
    公开号:US20060223810A1
    公开(公告)日:2006-10-05
    Antibacterial compounds, compositions containing them, and methods of use for the inhibition of bacterial activity and the treatment, prevention or inhibition of bacterial infection.
    抗菌化合物、含有它们的组合物以及用于抑制细菌活性以及治疗、预防或抑制细菌感染的方法。
  • [EN] NITROGEN-CONTAINING BICYCLIC HETEROCYCLES FOR USE AS ANTIBACTERIALS<br/>[FR] HETEROCYCLES BICYCLIQUES CONTENANT DE L'AZOTE ET UTILISES COMME PRODUITS ANTIBACTERIENS
    申请人:SMITHKLINE BEECHAM PLC
    公开号:WO2003087098A1
    公开(公告)日:2003-10-23
    Cyclohexane and cyclohexene derivatives and pharmaceutically acceptable derivatives hereof useful in methods of treatment of bacterial infections in mammals, particularly man.
    环己烷和环己烯衍生物及其在哺乳动物,特别是人类细菌感染治疗方法中有用的药用可接受衍生物。
  • [EN] NOVEL COMPOUNDS HAVING AN ANTI-BACTERIAL ACTIVITY<br/>[FR] NOUVEAUX COMPOSES PRESENTANT UNE ACTIVITE ANTIBACTERIENNE
    申请人:CHEMIE MORPHOCHEM AG FUER KOMB
    公开号:WO2006021448A1
    公开(公告)日:2006-03-02
    The present invention describes novel anti-bacterial compounds of formula (I). These compounds are, amongst others, of interest as inhibitors of DNA gyrase.
    本发明描述了具有通式(I)的新型抗菌化合物。这些化合物在其他方面,尤其是作为DNA促旋酶抑制剂,具有研究价值。
查看更多